Stocks · Health care · Pharmaceutical Preparations

Viking Therapeutics, Inc.

VKTX Clue Score32
United States Fiscal year ends December CIK 0001607678 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Marianna Mancini
29 Jul 2026
Chief Operating Officer
Sell
18,217
$33.47
$609.64K
Greg Zante
29 Jul 2026
Chief Financial Officer
Sell
21,217
$33.47
$710.14K
Brian Lian
29 Jul 2026
President & CEO
Sell
148,517
$33.32
$4.95M
Neil William Aubuchon
10 Mar 2026
Chief Commercial Officer
Buy
4,475
$33.50
$149.91K
Brian Lian
5 Jan 2026
President & CEO
Sell
6,400
$35.07
$224.42K
Brian Lian
5 Jan 2026
President & CEO
Sell
41,276
$34.22
$1.41M
Brian Lian
5 Jan 2026
President & CEO
Sell
53,279
$33.38
$1.78M
Brian Lian
5 Jan 2026
President & CEO
Sell
132,454
$32.29
$4.28M
Marianna Mancini
5 Jan 2026
Chief Operating Officer
Sell
1,600
$35.07
$56.12K
Marianna Mancini
5 Jan 2026
Chief Operating Officer
Sell
10,500
$34.22
$359.30K
Marianna Mancini
5 Jan 2026
Chief Operating Officer
Sell
13,600
$33.37
$453.88K
Marianna Mancini
5 Jan 2026
Chief Operating Officer
Sell
31,961
$32.29
$1.03M
Greg Zante
5 Jan 2026
Chief Financial Officer
Sell
1,500
$32.09
$48.13K
Greg Zante
5 Jan 2026
Chief Financial Officer
Sell
10,300
$34.24
$352.63K
Greg Zante
5 Jan 2026
Chief Financial Officer
Sell
13,900
$33.38
$464.02K
Greg Zante
5 Jan 2026
Chief Financial Officer
Sell
31,961
$32.30
$1.03M
Matthew W Foehr
2 Jan 2026
Director
Sold after exercise
16,000
$35.11
$561.69K

What was left out

Form 4 filings counted 15
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 771,662
History held since 30 Apr 2015